Patents by Inventor Kim Hewitt

Kim Hewitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IAP BIR domain binding compounds
    Patent number: 8063095
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: November 22, 2011
    Assignee: Pharmascience Inc.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Patent number: 7795298
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: September 14, 2010
    Assignee: Aegera Therapeutics, Inc.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Patent number: 7589118
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: September 15, 2009
    Assignee: Aegera Therapeutics, Inc.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris
  • IAP BIR domain binding compounds
    Publication number: 20080014207
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Application
    Filed: December 1, 2006
    Publication date: January 17, 2008
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Publication number: 20070219140
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substitutents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Application
    Filed: December 4, 2006
    Publication date: September 20, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Publication number: 20070093429
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Application
    Filed: December 4, 2006
    Publication date: April 26, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith